Oxford MEStar Overview
- Year Founded
-
2013

- Status
-
Private
- Employees
-
8

- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$6.64M
- Investors
-
4
Oxford MEStar General Information
Description
Developer of bioengineering products and services intended to serve the translational and regenerative medicine industry. The company's products offer to scale up human cells stem cell processing, manufacture of engineered tissues and cellular bioproducts and possess technical expertise in bioprocessing, bioengineering, and bio-manufacturing developing technologies for tissue engineering and stem cell therapy, enabling clients to get access to 3D bioprinting, in-vitro diagnostic development and other bio-engineering alternatives.
Contact Information
Website
www.oxford-mestar.comCorporate Office
- Centre for Innovation & Enterprise
- Begbroke Science Park
- Oxford OX5 1PF
- England, United Kingdom
Corporate Office
- Centre for Innovation & Enterprise
- Begbroke Science Park
- Oxford OX5 1PF
- England, United Kingdom
Oxford MEStar Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Grant | 21-Dec-2017 | $6.64M | Completed | Generating Revenue | ||
4. Early Stage VC | 30-Aug-2016 | Completed | Generating Revenue | |||
3. Early Stage VC | 16-Dec-2014 | Completed | Generating Revenue | |||
2. Early Stage VC | 01-Dec-2013 | $1.61M | $1.61M | Completed | Startup | |
1. University Spin-Out | 28-Oct-2013 | Completed | Startup |
Oxford MEStar Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | 197 | $0.013086 | $1660.64 | $1660.64 | 1x | $1660.64 | 7.66% | |
Ordinary | 275 | $0.013086 | $1665.47 | $1665.47 | 1x | $1665.47 | 10.69% |
Oxford MEStar Patents
Oxford MEStar Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-202001306-D0 | Cytometry flow cell, system and method | Active | 30-Jan-2020 | ||
GB-2591495-A | Cytometry flow cell, system and method | Active | 30-Jan-2020 | ||
GB-2591495-B | Cytometry flow cell, system and method | Active | 30-Jan-2020 | ||
US-20160047824-A1 | Personal test device | Inactive | 12-Nov-2012 | ||
EP-2917725-B1 | Personal test device | Inactive | 12-Nov-2012 | G01N33/726 |
Oxford MEStar Signals
Oxford MEStar Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Biotechnology and Biological Sciences Research Council | Government | |||
European Union | Government | |||
Innovate UK | Government | |||
University of Oxford | University |
Oxford MEStar FAQs
-
When was Oxford MEStar founded?
Oxford MEStar was founded in 2013.
-
Where is Oxford MEStar headquartered?
Oxford MEStar is headquartered in Oxford, United Kingdom.
-
What is the size of Oxford MEStar?
Oxford MEStar has 8 total employees.
-
What industry is Oxford MEStar in?
Oxford MEStar’s primary industry is Biotechnology.
-
Is Oxford MEStar a private or public company?
Oxford MEStar is a Private company.
-
What is Oxford MEStar’s current revenue?
The current revenue for Oxford MEStar is
. -
How much funding has Oxford MEStar raised over time?
Oxford MEStar has raised $4.25M.
-
Who are Oxford MEStar’s investors?
Biotechnology and Biological Sciences Research Council, European Union, Innovate UK, and University of Oxford have invested in Oxford MEStar.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »